We also analysed gabarapl1 mRNA expression in a retrospective cohort of 265 breast tumour biopsy samples using a reverse transcriptase–quantitative polymerase chain reaction (RT–qPCR) protocol to estimate its potential prognostic effect. The gene discussed is GABARAPL1; the disease is breast neoplasm.